Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Medical connector
Method of manufacturing a semiconductor device
Compositions and methods for the production of S-adenosylmethionine within the body
Torsion bar assembly and method, particularly for rail vehicle anti-roll bar
IP phone routing and call initiation based on location information
System and method for periodic body scan differencing
  Randomly Featured Patents
Developing device and image forming apparatus
Backflow prevention sleeve for suctioning devices
Method of manufacturing a diamond film coated cutting tool
Diagnostic jumper
Monodisperse aerosol generator for use with infrared spectrometry
Rotary valve internal combustion engine
Sliding track assembly
Animal control system having correction monitor
Cholesterol-rich fraction useful in culture media and process of producing same
N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (NK1) and/or neurokinin 2 (NK2) receptor antagonists